Cardiologists Argue It's Time to Abandon the Left Ventricular Noncompaction Diagnosis
Leading cardiac researchers challenge LVNC as a valid diagnosis, arguing the morphological pattern is a flawed basis for clinical decision-making.
Cardiovascular health, heart failure, atherosclerosis, and cardiac research
460 articles
Leading cardiac researchers challenge LVNC as a valid diagnosis, arguing the morphological pattern is a flawed basis for clinical decision-making.
Dive deep into the molecular mechanisms of vascular aging and explore cutting-edge interventions — from senolytic therapies and nitric oxide restoration to exercise-induced remodeling and emerging pharmacological approaches — that are redefining what's possible in cardiovascular longevity.
Discover how your arteries, veins, and capillaries work — and why the changes they undergo over time are one of the most important factors in how long and how well you live.
Leading cardiologists respond to reader questions on physiologic pacing strategies for heart failure patients, refining clinical guidance.
The TIGHT K trial's 6-month follow-up reveals how potassium supplementation thresholds during cardiac surgery recovery affect longer-term outcomes.
A JAMA review synthesizes evidence showing CRT significantly reduces mortality and hospitalizations in heart failure patients with electrical dyssynchrony.
A Harvard-affiliated clinician challenges assumptions about when defibrillation is truly advised in cardiac emergencies.
A 330-patient multicenter RCT tests whether thymosin α1 can curb immune dysregulation and organ dysfunction after acute type A aortic dissection repair.
Major cardiology societies overhaul training requirements for cardiac electrophysiology fellows, reflecting a decade of advances in arrhythmia care.
A 160-patient RCT shows LBBP dramatically reduces pacing-induced cardiomyopathy and preserves heart function over 3 years.
A 965-patient RCT shows omitting defibrillation testing during subcutaneous ICD implantation is non-inferior to routine testing when device position is scored by chest X-ray.
A protein linked to cardiovascular protection predicts mitral valve deterioration and heart failure risk after STEMI, opening a new prognostic window.